Innovative breath-based device aims to revolutionize blood glucose monitoring.
A Game-Changer for Diabetes Management
PreEvnt has unveiled Isaac, a non-invasive device that uses breath analysis to monitor blood glucose levels. Designed to reduce the need for fingersticks, Isaac offers a convenient solution for people with type 1, type 2, or pre-diabetes and others interested in tracking their glucose levels.
Key Features of Isaac:
- Breath-based detection: Utilizes Nanoz’s patented MOx technology to identify volatile organic compounds (VOCs) like acetone in exhaled breath.
- Custom app integration: Tracks glucose data and offers real-time alerts via iOS and Android apps, with options to share information with family and physicians.
- Portable design: Small enough to wear on a lanyard or clip to a pocket.
- Rechargeable battery: A single USB-C charge lasts all day.
Pioneering Technology for Real-Time Insights
Isaac provides real-time glucose readings, enabling users to make informed decisions about diet and exercise. It also features customizable alerts to warn users of elevated glucose levels, offering a proactive approach to glucose management.
Dr. M. Agarwal of Indiana University, who led the development of the technology, explained: “This technology mimics the capabilities of diabetes alert dogs, offering a noninvasive and reliable monitoring solution.”
FDA Review Pending
Currently investigational, Isaac is under development and awaits FDA review. This follows a 2024 FDA warning against unauthorized non-invasive glucose monitoring devices, emphasizing the need for regulatory approval to ensure safety and accuracy.
Debuting at CES 2025
PreEvnt, a subsidiary of Scosche Industries, plans to showcase Isaac at CES 2025. The device aligns with growing consumer interest in non-invasive glucose monitoring, spurred by over-the-counter CGMs from Abbott and Dexcom.
Transforming Diabetes Care
Isaac has the potential to set a new standard in diabetes management with its innovative, non-invasive approach, empowering users to monitor glucose levels effortlessly.
Follow MEDWIRE.AI for the latest advancements in diabetes care and health technology.
